Showing results (2601-2610 of 6,717) with videos related to
Sort By:
Pageof 672
Oncotargets and Therapy|November 20, 2013
The Hedgehog inhibitor cyclopamine antagonizes chemoresistance of breast cancer cellsFeng Chai, Jiangang Zhou, Cheng Chen, et al.Oncotargets and Therapy|October 22, 2013
Targeting hedgehog signaling in cancer: research and clinical developmentsJingwu Xie, Christopher M Bartels, Scott W Barton, et al.Oncotargets and Therapy|November 22, 2013
Prognostic factors associated with solitary plasmacytomaShan-Qi Guo, Le Zhang, Ya-Fei Wang, et al.Oncotargets and Therapy|August 26, 2014
Glucagonoma syndrome: a case report with focus on skin disordersSheng Fang, Shuang Li, Tao CaiOncotargets and Therapy|September 5, 2014
High infiltration of tumor-associated macrophages in triple-negative breast cancer is associated with a higher risk of distant metastasisZhong-Yu Yuan, Rong-Zhen Luo, Rou-Jun Peng, et al.Oncotargets and Therapy|September 5, 2014
miR-129 as a novel therapeutic target and biomarker in gastrointestinal cancerAndrew Fesler, Haiyan Zhai, Jingfang JuOncotargets and Therapy|December 19, 2013
Gemcitabine and carboplatin demonstrate synergistic cytotoxicity in cervical cancer cells by inhibiting DNA synthesis and increasing cell apoptosisGuixiu Jin, Jing Zhao, Hongyan Qi, et al.Oncotargets and Therapy|December 19, 2013
The potential for targeting extracellular LOX proteins in human malignancyAlejandro Mayorca-Guiliani, Janine T ErlerOncotargets and Therapy|December 19, 2013
Signal transduction molecule patterns indicating potential glioblastoma therapy approachesMaria Linda Cruceru, Ana-Maria Enciu, Adrian Claudiu Popa, et al.Oncotargets and Therapy|December 19, 2013
Sequential treatment of tyrosine kinase inhibitors and chemotherapy for EGFR-mutated non-small cell lung cancer: a meta-analysis of Phase III trialsYiliang Zhang, Yihua Sun, Lei Wang, et al.Pageof 672